- Home
- Publications
- Publication Search
- Publication Details
Title
Breast Cancer Genomics: Primary and Most Common Metastases
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 13, Pages 3046
Publisher
MDPI AG
Online
2022-06-22
DOI
10.3390/cancers14133046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LncRNA MNX1-AS1: A novel oncogenic propellant in cancers
- (2022) Tengfei Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
- (2022) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- PARP inhibition in breast cancer: progress made and future hopes
- (2022) Nadine Tung et al. npj Breast Cancer
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MAT2A inhibition blocks the growth of MTAP-deleted cancer cells by reducing PRMT5-dependent mRNA splicing and inducing DNA damage
- (2021) Peter Kalev et al. CANCER CELL
- The ESR1 Mutations: From Bedside to Bench to Bedside
- (2021) Francisco Hermida-Prado et al. CANCER RESEARCH
- Prognosis and Genomic Landscape of Liver Metastasis in Patients With Breast Cancer
- (2021) Chonglin Tian et al. Frontiers in Oncology
- Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous MTAP Deletion
- (2021) Zenon Konteatis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Correlation between family history and characteristics of breast cancer
- (2021) Lei Liu et al. Scientific Reports
- Gene expression profiles of breast cancer metastasis according to organ site
- (2021) Fara Brasó‐Maristany et al. Molecular Oncology
- INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer
- (2021) Samuel J. Rodgers et al. Nature Communications
- Current and Future Management of HER2-Positive Metastatic Breast Cancer
- (2021) Olga Martínez-Sáez et al. JCO Oncology Practice
- Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer
- (2021) Cenzhu Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)
- (2020) Richard S. Finn et al. BREAST CANCER RESEARCH AND TREATMENT
- Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets
- (2020) Matt R. Paul et al. JOURNAL OF CLINICAL INVESTIGATION
- The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer
- (2020) Aena Patel et al. Cancers
- Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3
- (2020) Junhua Li et al. Frontiers in Oncology
- Comparison of Mortality Among Participants of Women’s Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers
- (2020) Veronica L. Irvin et al. JAMA Network Open
- Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers
- (2020) Kuo Chen et al. SEMINARS IN CANCER BIOLOGY
- The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives
- (2020) Maria Francesca Santolla et al. Cancers
- Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1
- (2020) F. André et al. ANNALS OF ONCOLOGY
- Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis
- (2020) Chiara Spadazzi et al. BONE
- Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
- (2019) H. S. Rugo et al. BREAST CANCER RESEARCH AND TREATMENT
- Biomarkers to diagnose metastatic breast carcinoma to the pancreas: A case report and update
- (2019) Kevin Shee et al. DIAGNOSTIC CYTOPATHOLOGY
- Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives
- (2019) Braeden Medeiros et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genomic characterization of metastatic breast cancers
- (2019) François Bertucci et al. NATURE
- ESR1 mutations in breast cancer
- (2019) Derek Dustin et al. CANCER
- FGFR1 gene amplification mediates endocrine resistance but retains TORC sensitivity in metastatic hormone receptor positive (HR+) breast cancer
- (2019) Joshua Z Drago et al. CLINICAL CANCER RESEARCH
- Rare sites of breast cancer metastasis: a review
- (2019) Rosa Di Micco et al. Translational Cancer Research
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Breast cancer lung metastasis: Molecular biology and therapeutic implications
- (2018) Liting Jin et al. CANCER BIOLOGY & THERAPY
- Systematic Functional Annotation of Somatic Mutations in Cancer
- (2018) Patrick Kwok-Shing Ng et al. CANCER CELL
- High-throughput functional evaluation of variants of unknown significance in ERBB2
- (2018) Masaaki Nagano et al. CLINICAL CANCER RESEARCH
- Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis
- (2018) Meysam Yousefi et al. CELLULAR ONCOLOGY
- Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer
- (2018) Alvaro Avivar-Valderas et al. Oncotarget
- Molecular subtypes of screen-detected breast cancer
- (2018) Gelareh Farshid et al. BREAST CANCER RESEARCH AND TREATMENT
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
- (2018) Pedram Razavi et al. CANCER CELL
- Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions
- (2018) Ruth M. Pfeiffer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis
- (2018) Miho Kono et al. Journal of Cancer
- Expression, Clinical Significance and Functional Prediction of MNX1 in Breast Cancer
- (2018) Tian Tian et al. Molecular Therapy-Nucleic Acids
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse
- (2017) Jing Yang et al. TUMOR BIOLOGY
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- (2017) Cancer Discovery
- MAPK, NFκB, and VEGF signaling pathways regulate breast cancer liver metastasis
- (2017) Xinhua Chen et al. Oncotarget
- Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
- (2017) Qi Wu et al. Oncotarget
- Computational Methods for Characterizing Cancer Mutational Heterogeneity
- (2017) Fabio Vandin Frontiers in Genetics
- The genomic landscape of breast cancer and its interaction with host immunity
- (2016) Stephen Luen et al. BREAST
- Orbital Metastases from Breast Cancer: Retrospective Analysis at an Academic Cancer Center
- (2016) Tiffany M. Pierson et al. Breast Journal
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- Breast Cancer Subtypes Predispose the Site of Distant Metastases
- (2015) Abha Soni et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Subclonal diversification of primary breast cancer revealed by multiregion sequencing
- (2015) Lucy R Yates et al. NATURE MEDICINE
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- (2015) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2
- (2015) L Jia et al. ONCOGENE
- Diagnostic Intervals and Its Association with Breast, Prostate, Lung and Colorectal Cancer Survival in England: Historical Cohort Study Using the Clinical Practice Research Datalink
- (2015) Maria Theresa Redaniel et al. PLoS One
- BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5
- (2015) Junying Qin et al. Nature Communications
- The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1
- (2015) Chunyan Wang et al. Oncotarget
- Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
- (2015) Charlotte KY Ng et al. GENOME BIOLOGY
- Breast Cancer Screening, Incidence, and Mortality Across US Counties
- (2015) Charles Harding et al. JAMA Internal Medicine
- Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1
- (2015) L V Rhodes et al. Oncogenesis
- Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis
- (2014) Bodour Salhia et al. PLoS One
- Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention
- (2014) F. J. Couch et al. SCIENCE
- High frequency of lobular breast cancer in distant metastases to the orbit
- (2014) Mieke Raap et al. Cancer Medicine
- Phosphoinositide 3-kinase and INPP4B in human breast cancer
- (2013) Micka C. Bertucci et al. Annals of the New York Academy of Sciences
- Krüppel-like Factor 5 Transcription Factor Promotes Microsomal Prostaglandin E2Synthase 1 Gene Transcription in Breast Cancer
- (2013) Houjun Xia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Analysis of 2,480 Space-Occupying Lesions of the Orbit From 1976 to 2011
- (2013) Giulio Bonavolontà et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers
- (2013) Maria B. Raeder et al. PLoS One
- Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer
- (2012) Shuling Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The landscape of cancer genes and mutational processes in breast cancer
- (2012) Philip J. Stephens et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
- (2012) Archie Bleyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity
- (2011) Joseph R. Bertino et al. CANCER BIOLOGY & THERAPY
- Breast Cancer Screening: A 35-Year Perspective
- (2011) Suzanne W. Fletcher EPIDEMIOLOGIC REVIEWS
- Role of Pro-oncogenic Protein Disulfide Isomerase (PDI) Family Member Anterior Gradient 2 (AGR2) in the Control of Endoplasmic Reticulum Homeostasis
- (2011) Arisa Higa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Independent Prognostic Value of Screen Detection in Invasive Breast Cancer
- (2011) Stella Mook et al. JNCI-Journal of the National Cancer Institute
- Tumor Characteristics Associated With Mammographic Detection of Breast Cancer in the Ontario Breast Screening Program
- (2011) V. A. Kirsh et al. JNCI-Journal of the National Cancer Institute
- Pancreatic metastases from renal cell carcinoma: The state of the art
- (2011) Roberto Ballarin WORLD JOURNAL OF GASTROENTEROLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- The molecular pathology of breast cancer progression
- (2010) Alessandro Bombonati et al. JOURNAL OF PATHOLOGY
- Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications
- (2009) N. Cabioglu et al. ANNALS OF ONCOLOGY
- E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
- (2009) Otto Schmalhofer et al. CANCER AND METASTASIS REVIEWS
- ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors
- (2009) M. Ciro et al. CANCER RESEARCH
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1
- (2009) H -Q Zheng et al. ONCOGENE
- Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
- (2008) G C Wishart et al. BRITISH JOURNAL OF CANCER
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes
- (2007) Emad A. Rakha et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started